ketodarolutamide developmental code names nonsteroidal antiandrogen nsaa major active metabolite darolutamide nsaa used treatment prostate cancer similarly parent compound ketodarolutamide acts highly selective highaffinity competitive silent antagonist androgen receptor agents show much higher affinity potent inhibition ar relative nsaas enzalutamide apalutamide although also possess much shorter comparatively less favorable elimination also found activate certain mutant ar variants enzalutamide apalutamide darolutamide ketodarolutamide show limited central nervous system distribution indicating peripheral selectivity little inhibition induction cytochrome enzymes unlike enzalutamide antineoplastic immunomodulatory drug article stub help wikipedia expanding ithttpsenwikipediaorgwikiketodarolutamide